Matches in Nanopublications for { ?s ?p "[We exposed the androgen-independent/androgen receptor (AR)-negative prostate cancer cell line DU145 to NGF to study whether this neurotrophin could revert DU145 cells to a less malignant phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP266911.RAQ7u39TH7zOO3Xsov0djj72TRZqRXXOfXnESUSy8pZsU130_assertion description "[We exposed the androgen-independent/androgen receptor (AR)-negative prostate cancer cell line DU145 to NGF to study whether this neurotrophin could revert DU145 cells to a less malignant phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266911.RAQ7u39TH7zOO3Xsov0djj72TRZqRXXOfXnESUSy8pZsU130_provenance.
- assertion description "[We exposed the androgen-independent/androgen receptor (AR)-negative prostate cancer cell line DU145 to NGF to study whether this neurotrophin could revert DU145 cells to a less malignant phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We exposed the androgen-independent/androgen receptor (AR)-negative prostate cancer cell line DU145 to NGF to study whether this neurotrophin could revert DU145 cells to a less malignant phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP266839.RAMTokFkW5THmjxw5ySWIahOdnAr7AqObfsPRcWy2jDPo130_assertion description "[We exposed the androgen-independent/androgen receptor (AR)-negative prostate cancer cell line DU145 to NGF to study whether this neurotrophin could revert DU145 cells to a less malignant phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266839.RAMTokFkW5THmjxw5ySWIahOdnAr7AqObfsPRcWy2jDPo130_provenance.
- NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_assertion description "[We exposed the androgen-independent/androgen receptor (AR)-negative prostate cancer cell line DU145 to NGF to study whether this neurotrophin could revert DU145 cells to a less malignant phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_provenance.
- NP366920.RAF-_bIKeeu3JOydTttbl3600DunV8S6nzpwxmV7V44MM130_assertion description "[We exposed the androgen-independent/androgen receptor (AR)-negative prostate cancer cell line DU145 to NGF to study whether this neurotrophin could revert DU145 cells to a less malignant phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP366920.RAF-_bIKeeu3JOydTttbl3600DunV8S6nzpwxmV7V44MM130_provenance.